For example, investigations of T cell infiltrates in uveal melanoma revealed CD39+PD-1+CD8+ T-cell enrichment in high-risk M3 tumors (78), but these findings were based on localized tumor samples and have not been extensively validated across melanoma subtypes or diverse patient populations. This evidence concerns the gene PDCD1 and neoplasm.